Please use this identifier to cite or link to this item: https://scidar.kg.ac.rs/handle/123456789/8276
Title: Association between Galectin-3 levels within central and peripheral venous blood, and adverse left ventricular remodelling after first acute myocardial infarction
Authors: Andrejić O.
Vucic, Rada
Pavlović, Milan
McClements, Lana
Stokanovic, Dragana
Jevtovic–Stoimenov T.
Nikolic V.
Issue Date: 2019
Abstract: © 2019, The Author(s). Our study investigates association between Galectin-3 levels and adverse left ventricular remodelling (LVR) at six months. Fifty-seven patients following first acute myocardial infarction (AMI) were enrolled in this study and blood samples collected on day 1 from the femoral vein and artery, the right atrium near the coronary sinus and the aortic root, and on day 30, from the cubital vein. Patients with LVESV ≥20% at six months, were included in the LVR group. On day 1, Galectin-3 plasma levels in the femoral vein (10.34 ng/ml ± 3.81 vs 8.22 ng/ml ± 2.34, p = 0.01), and near coronary sinus (10.7 ng/ml ± 3.97 vs 8.41 ng/ml ± 2.56, p = 0.007) were higher in the LVR group. Positive correlations between Galectin-3 levels from aortic root and coronary sinus, aortic root and femoral vein, and coronary sinus and femoral vein, were observed in both groups. On day 30, Galectin-3 concentration in the cubital vein was an independent risk factor of LVR six months post-AMI, demonstrating 1.5-fold increased risk. Day-30 Galectin-3 also showed positive correlations with echocardiography parameters indicative of diastolic and systolic dysfunction. Determining Galectin-3 plasma concentration on day 30 following AMI could have beneficial prognostic value in predicting LVR.
URI: https://scidar.kg.ac.rs/handle/123456789/8276
Type: article
DOI: 10.1038/s41598-019-49511-4
SCOPUS: 2-s2.0-85072116448
Appears in Collections:Faculty of Medical Sciences, Kragujevac

Page views(s)

119

Downloads(s)

7

Files in This Item:
File Description SizeFormat 
10.1038-s41598-019-49511-4.pdf1.06 MBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons